Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1972 1
1977 1
1978 1
1979 1
1982 2
1983 3
1984 2
1985 1
1988 2
1989 1
1991 1
1992 1
1993 3
1994 3
1995 2
1996 4
1997 2
1998 5
1999 11
2000 8
2001 14
2002 7
2003 5
2004 12
2005 14
2006 16
2007 18
2008 13
2009 10
2010 15
2011 15
2012 19
2013 19
2014 19
2015 24
2016 32
2017 37
2018 30
2019 26
2020 42
2021 50
2022 49
2023 33
2024 46
2025 45
2026 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

601 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ksukahara k[au] (1 results)?
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease.
Ban T, Kikuchi M, Sato GR, Manabe A, Tagata N, Harita K, Nishiyama A, Nishimura K, Yoshimi R, Kirino Y, Yanai H, Matsumoto Y, Suzuki S, Hihara H, Ito M, Tsukahara K, Yoshimatsu K, Yamamoto T, Taniguchi T, Nakajima H, Ito S, Tamura T. Ban T, et al. Among authors: tsukahara k. Nat Commun. 2021 Jul 19;12(1):4379. doi: 10.1038/s41467-021-24609-4. Nat Commun. 2021. PMID: 34282144 Free PMC article.
Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial.
Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, Kimura T; ONCO DVT Study Investigators. Yamashita Y, et al. Among authors: tsukahara k. Circulation. 2023 Nov 21;148(21):1665-1676. doi: 10.1161/CIRCULATIONAHA.123.066360. Epub 2023 Aug 28. Circulation. 2023. PMID: 37638968 Free article. Clinical Trial.
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).
Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Chatani R, Shibata T, Nishimoto Y, Ogihara Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Tsukahara K, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Ono K, Kimura T; ONCO PE Trial Investigators. Yamashita Y, et al. Among authors: tsukahara k. Circulation. 2025 Mar 4;151(9):589-600. doi: 10.1161/CIRCULATIONAHA.124.072758. Epub 2024 Nov 18. Circulation. 2025. PMID: 39556015 Free PMC article. Clinical Trial.
Authors' reply.
Tsukahara K. Tsukahara K. J Cardiol. 2017 Oct;70(4):403. doi: 10.1016/j.jjcc.2017.03.003. Epub 2017 Apr 3. J Cardiol. 2017. PMID: 28385498 Free article. No abstract available.
The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapy.
Kano S, Kawakita D, Honma Y, Takahashi H, Nakaguro M, Utsumi Y, Saigusa N, Hanazawa T, Tsukahara K, Okada T, Okami K, Yamazaki K, Ueki Y, Saito Y, Ozawa H, Arai T, Shimizu A, Hanyu K, Iwaki S, Imaizumi S, Sakai A, Yamauchi M, Tanaka R, Sato Y, Yamamura K, Sekimizu M, Imanishi Y, Hirai H, Sato Y, Urano M, Yamamoto H, Fushimi C, Matsuki T, Nagao T, Tada Y; Multi-institutional Joint SDC Study Group in Japan. Kano S, et al. Among authors: tsukahara k. Oral Oncol. 2025 Jun;165:107280. doi: 10.1016/j.oraloncology.2025.107280. Epub 2025 Apr 18. Oral Oncol. 2025. PMID: 40252453 Free article.
Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma.
Tsujikawa T, Ohno K, Morita KI, Saburi S, Mitsuda J, Yoshimura K, Kimura A, Morimoto H, Ogi H, Shibata S, Akashi T, Kurata M, Imoto I, Shimizu Y, Kano S, Watanabe A, Yamazaki T, Asada Y, Hayashi R, Saito Y, Ozawa H, Tsukahara K, Oridate N, Sano D, Horii A, Ueki Y, Maruo T, Mukoyama N, Hanai N, Fukusumi T, Iwai H, Fujisawa T, Fujii T, Nibu KI, Iwae S, Ueda T, Chikuie N, Yasumatsu R, Matsuo M, Umeno H, Ono T, Masuda M, Toh S, Itoh K, Hirano S, Asakage T. Tsujikawa T, et al. Among authors: tsukahara k. Front Immunol. 2024 Jul 29;15:1390873. doi: 10.3389/fimmu.2024.1390873. eCollection 2024. Front Immunol. 2024. PMID: 39136017 Free PMC article.
Prolonged Edoxaban in Patients With Low Body Weight and Cancer-Associated Isolated Distal Deep Vein Thrombosis.
Nagai T, Nakanishi N, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Kim K, Ikeda S, Kimura T, Matoba S; ONCO DVT Study Investigators. Nagai T, et al. Among authors: tsukahara k. JACC Adv. 2025 Aug;4(8):101956. doi: 10.1016/j.jacadv.2025.101956. Epub 2025 Jul 4. JACC Adv. 2025. PMID: 40616931 Free PMC article.
Cytoplasmic p53 Immunostaining in Salivary Duct Carcinoma: A Poor Prognostic Factor Associated With Characteristic TP53 Variants.
Utsumi Y, Nakaguro M, Kawakita D, Hirai H, Sukeda A, Kohsaka S, Tsukahara K, Hanazawa T, Kano S, Yamazaki K, Ueki Y, Okami K, Saito Y, Ozawa H, Honma Y, Shimizu A, Hanyu K, Fujii S, Arai T, Iwaki S, Imaizumi S, Tanaka R, Yamauchi M, Yamamura K, Sekimizu M, Takahashi H, Imanishi Y, Sato Y, Matsuki T, Tada Y, Nagao T; Multi-institutional Joint SDC Study Group in Japan. Utsumi Y, et al. Among authors: tsukahara k. Mod Pathol. 2025 Jul;38(7):100766. doi: 10.1016/j.modpat.2025.100766. Epub 2025 Apr 7. Mod Pathol. 2025. PMID: 40204093
Clinical outcomes of cancer-associated isolated distal deep vein thrombosis: a comparison between asymptomatic and symptomatic thrombosis-findings from the ONCO DVT Study.
Ogihara Y, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Sato T, Kimura T, Dohi K; ONCO DVT Study Investigators. Ogihara Y, et al. Among authors: tsukahara k. Res Pract Thromb Haemost. 2025 Mar 6;9(2):102722. doi: 10.1016/j.rpth.2025.102722. eCollection 2025 Feb. Res Pract Thromb Haemost. 2025. PMID: 40224278 Free PMC article.
601 results